| XLS |
|
Key figures of the Merck Group |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ million |
Pharma- |
Chemicals |
Corporate |
Total |
Change |
|
Total revenues |
6,416.2 |
3,860.2 |
– |
10,276.4 |
11 |
|
Gross margin |
5,227.0 |
2,261.1 |
– |
7,488.1 |
8.4 |
|
Research and development |
1,248.3 |
268.8 |
– |
1,517.1 |
8.6 |
|
Operating result |
350.3 |
751.0 |
–116.2 |
985.1 |
–12 |
|
Exceptional items |
25.1 |
157.1 |
–30.4 |
151.8 |
– |
|
EBIT before depreciation and amortization (EBITDA) |
1,571.7 |
1,305.1 |
–141.1 |
2,735.7 |
11 |
|
Earnings before interest and tax (EBIT) |
375.4 |
908.1 |
–146.6 |
1,136.9 |
2.2 |
|
Return on sales in % (ROS: operating result/total revenues) |
5.5 |
19.5 |
– |
9.6 |
|
|
Free cash flow |
1,515.1 |
834.0 |
–912.7 |
1,436.4 |
– |
|
Underlying free cash flow |
1,245.0 |
801.3 |
–651.7 |
1,394.6 |
–17 |
Total revenues by business sector
Operating result by business sector
